Nature Reviews Clinical Oncology Referencing Guide · Nature Reviews Clinical Oncology citation (updated Aug 15 2022) · Citationsy
Collections | Nature Reviews Clinical Oncology
Volume 16 | Nature Reviews Clinical Oncology
2020 Nature Cancer Immunotherapy Calendar | OriGene
Volume 9 | Nature Reviews Clinical Oncology
Volume 19 Issue 8, August 2022
Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach? | Nature Reviews Clinical Oncology
Imaging biomarker roadmap for cancer studies | Nature Reviews Clinical Oncology
Volume 18 Issue 9, September 2021
Volume 13 | Nature Reviews Clinical Oncology
Volume 4 | Nature Reviews Clinical Oncology
Article Series: Nature Reviews Clinical Oncology
Volume 18 | Nature Reviews Clinical Oncology
Volume 14 | Nature Reviews Clinical Oncology
Volume 15 | Nature Reviews Clinical Oncology
Nature Reviews - Nature Reviews Clinical Oncology: Telomerase reverse transcriptase (TERT) is expressed constitutively in tumour cells throughout the evolution of many cancers; therefore, this potential tumour self-antigen has been an important
Tumour heterogeneity and resistance to cancer therapies | Nature Reviews Clinical Oncology
Volume 8 | Nature Reviews Clinical Oncology
Volume 16 | Nature Reviews Clinical Oncology
Volume 19 Issue 6, June 2022
Reach An Oncology Audience - Nature Research Partnerships
Volume 17 | Nature Reviews Clinical Oncology
Volume 19 | Nature Reviews Clinical Oncology
Chimeric antigen receptor T-cell therapies for lymphoma | Nature Reviews Clinical Oncology
